As expected, our present study has demonstrated that anti-apoptotic protein Bcl-2 was decreased, pro-apoptotic protein Bax was increased, and cleaved caspase 3 protein, reflective of caspase activity, a marker of apoptosis, was increased in doxorubicin cardiomyopathy. The gene discussed is BCL2; the disease is cardiomyopathy.